| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 728100 | 1191360 | WAYLIVRA 285 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA | WAYLIVRA 285 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA, 1 jeringa precargada de 1,5 ml | 285 mg inyectable 1,5 ml | 66 | 1 | 61 | 1 jeringa precargada de 1,5 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1191360/1191360_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191360/1191360_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 70091 | SWEDISH ORPHAN BIOVITRUM S.L. | 2020-03-02 | 1 | 1 | 1 | 2020-03-03 | 2020-03-02 | 1 | 2022-03-08 | View Edit Delete | ||||||||||||
| 731118 | 1191361002 | SKYRIZI 150 mg SOLUCION INYECTABLE EN PLUMA PRECARGADA | SKYRIZI 150 mg SOLUCION INYECTABLE EN PLUMA PRECARGADA, 1 pluma precargada de 1 ml | 150 mg inyectable 1 ml | 66 | 1 | 49 | 1 pluma precargada de 1 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1191361002/1191361002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191361002/1191361002_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 41086 | ABBVIE SPAIN, S.L.U. | 2021-06-28 | 1 | 1 | 1 | 2021-06-29 | 2021-06-28 | 1 | 2021-12-13 | View Edit Delete | ||||||||||||
| 731119 | 1191361003 | SKYRIZI 150 mg SOLUCION INYECTABLE EN JERINGA PRECARGADA | SKYRIZI 150 mg SOLUCION INYECTABLE EN JERINGA PRECARGADA, 1 jeringa precargada de 1 ml | 150 mg inyectable 1 ml | 33 | 1 | 61 | 1 jeringa precargada de 1 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1191361003/1191361003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191361003/1191361003_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 41086 | ABBVIE SPAIN, S.L.U. | 2021-06-28 | 1 | 1 | 1 | 2021-06-29 | 2021-06-28 | 1 | 2021-12-13 | View Edit Delete | ||||||||||||
| 759470 | 1191361004 | SKYRIZI 600 MG CONCENTRADO PARA SOLUCION PARA PERFUSION | SKYRIZI 600 MG CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 10 ml | 600 mg inyectable 10 ml | 45 | 1 | 34 | 1 vial de 10 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1191361004/1191361004_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191361004/1191361004_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 41086 | ABBVIE SPAIN, S.L.U. | 2022-12-15 | 1 | 1 | 1 | 2022-12-16 | 2022-12-15 | 1 | 2023-08-12 | View Edit Delete | ||||||||||||
| 759471 | 1191361005 | SKYRIZI 360 MG SOLUCION INYECTABLE EN CARTUCHO | SKYRIZI 360 MG SOLUCION INYECTABLE EN CARTUCHO, 1 cartucho de 2,4 ml y 1 inyector corporal | 360 mg inyectable 2,4 ml | 12 | 1 | 57 | 1 cartucho de 2,4 ml y 1 inyector corporal | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1191361005/1191361005_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191361005/1191361005_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 41086 | ABBVIE SPAIN, S.L.U. | 2022-12-15 | 1 | 1 | 1 | 2022-12-16 | 2022-12-15 | 1 | 2023-10-14 | View Edit Delete | ||||||||||||
| 765521 | 1191361007 | SKYRIZI 180 MG SOLUCION INYECTABLE EN CARTUCHO | SKYRIZI 180 MG SOLUCION INYECTABLE EN CARTUCHO, 1 cartucho de 1,2 ml y 1 inyector corporal | 180 mg inyectable 1,2 ml | 12 | 1 | 57 | 1 cartucho de 1,2 ml y 1 inyector corporal | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1191361007/1191361007_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191361007/1191361007_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 41086 | ABBVIE SPAIN, S.L.U. | 2024-08-01 | 1 | 1 | 1 | 2024-08-02 | 2024-08-01 | 1 | 2025-02-10 | View Edit Delete | ||||||||||||
| 732749 | 1191364002 | NUCEIVA 50 UNIDADES POLVO PARA SOLUCIÓN INYECTABLE | NUCEIVA 50 UNIDADES POLVO PARA SOLUCIÓN INYECTABLE, 1 vial | 50 U | 45 | 1 | 34 | 1 vial | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1191364002/1191364002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191364002/1191364002_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 40676 | EVOLUS PHARMA LIMITED | 2022-02-25 | 1 | 1 | 1 | 2022-02-26 | 2022-02-25 | 1 | 2024-05-02 | View Edit Delete | ||||||||||||
| 764717 | 1191364002 | NUCEIVA 50 UNIDADES POLVO PARA SOLUCIÓN INYECTABLE | NUCEIVA 50 UNIDADES POLVO PARA SOLUCIÓN INYECTABLE, 4 viales | 50 U | 45 | 4 | 34 | 4 viales | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1191364002/1191364002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191364002/1191364002_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 40676 | EVOLUS PHARMA LIMITED | 2022-02-25 | 1 | 1 | 1 | 2022-02-26 | 2024-04-11 | 1 | 2024-09-06 | View Edit Delete | ||||||||||||
| 729076 | 1191365001 | CUFENCE 200 MG CAPSULAS DURAS | CUFENCE 200 MG CAPSULAS DURAS, 100 cápsulas | 200 mg | 6 | 100 | 43 | 100 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1191365001/1191365001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191365001/1191365001_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 34763 | WAAS ANITA S.A. | 2020-10-06 | 1 | 1 | 1 | 2020-10-07 | 2020-10-06 | 1 | 2022-05-09 | View Edit Delete | ||||||||||||
| 726336 | 1191370001 | DOVATO 50 MG/300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | DOVATO 50 MG/300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, Frasco de 30 comprimidos | 50 mg/300 mg | 6 | 30 | 10 | Frasco de 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1191370001/1191370001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191370001/1191370001_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 34670 | LABORATORIOS VIIV HEALTHCARE S.L. | 2019-07-19 | 1 | 1 | 1 | 2019-07-20 | 2019-07-19 | 1 | 2019-12-12 | View Edit Delete | ||||||||||||
| 763454 | 1191370001 | DOVATO 50 MG/300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | DOVATO 50 MG/300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, Blíster de 30 comprimidos | 50 mg/300 mg | 5 | 30 | 10 | Blíster de 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1191370001/1191370001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191370001/1191370001_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 34670 | LABORATORIOS VIIV HEALTHCARE S.L. | 2019-07-19 | 1 | 1 | 1 | 2019-07-20 | 2023-09-26 | 1 | 2024-01-11 | View Edit Delete | ||||||||||||
| 731120 | 1191371002 | ULTOMIRIS 300 mg/3 ml CONCENTRADO PARA SOLUCION PARA PERFUSION | ULTOMIRIS 300 mg/3 ml CONCENTRADO PARA SOLUCION PARA PERFUSION 1 vial de 3 ml | 100 mg/ml inyectable 3 ml | 45 | 1 | 34 | 1 vial de 3 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1191371002/1191371002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191371002/1191371002_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 31986 | ALEXION PHARMA SPAIN S.L.U. | 2021-06-11 | 1 | 1 | 1 | 2021-06-12 | 2021-06-11 | 1 | 2022-05-13 | View Edit Delete | ||||||||||||
| 731121 | 1191371003 | ULTOMIRIS 1100 mg/11 ml CONCENTRADO PARA SOLUCION PARA PERFUSION | ULTOMIRIS 1100 mg/11 ml CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 11 ml | 100 mg/ml inyectable 11 ml | 45 | 1 | 34 | 1 vial de 11 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1191371003/1191371003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191371003/1191371003_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 31986 | ALEXION PHARMA SPAIN S.L.U. | 2021-06-11 | 1 | 1 | 1 | 2021-06-12 | 2021-06-11 | 1 | 2022-05-13 | View Edit Delete | ||||||||||||
| 726401 | 1191372001 | STRIASCAN 74 MBQ/ML SOLUCION INYECTABLE EFG | STRIASCAN 74 MBQ/ML SOLUCION INYECTABLE EFG, 1 vial de 2,5 ml | 74 MBq/ml inyectable 2,5 ml | 45 | 1 | 34 | 1 vial de 2,5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1191372001/1191372001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191372001/1191372001_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 689 | CURIUM PHARMA SPAIN S.A. | 2019-12-02 | 1 | 1 | 1 | 2019-12-03 | 2019-12-02 | 1 | 2021-03-24 | View Edit Delete | ||||||||||||
| 726402 | 1191372001 | STRIASCAN 74 MBQ/ML SOLUCION INYECTABLE EFG | STRIASCAN 74 MBQ/ML SOLUCION INYECTABLE EFG, 1 vial de 5 ml | 74 MBq/ml inyectable 5 ml | 45 | 1 | 34 | 1 vial de 5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1191372001/1191372001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191372001/1191372001_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 689 | CURIUM PHARMA SPAIN S.A. | 2019-12-02 | 1 | 1 | 1 | 2019-12-03 | 2019-12-02 | 1 | 2021-03-24 | View Edit Delete | ||||||||||||
| 728167 | 1191373 | DOPTELET 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | DOPTELET 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 10 comprimidos | 20 mg | 5 | 10 | 10 | 10 comprimidos | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1191373/1191373_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191373/1191373_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 15522 | SWEDISH ORPHAN BIOVITRUM S.L. | 2020-05-04 | 1 | 1 | 1 | 2020-05-05 | 2020-05-04 | 1 | 2021-02-24 | View Edit Delete | ||||||||||||
| 728168 | 1191373 | DOPTELET 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | DOPTELET 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 15 comprimidos | 20 mg | 5 | 15 | 10 | 15 comprimidos | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1191373/1191373_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191373/1191373_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 15522 | SWEDISH ORPHAN BIOVITRUM S.L. | 2020-05-04 | 1 | 1 | 1 | 2020-05-05 | 2020-05-04 | 1 | 2021-02-23 | View Edit Delete | ||||||||||||
| 726500 | 1191374001 | ESPEROCT 500 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | ESPEROCT 500 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE, 1 vial, 1 jeringa precargada, 1 émbolo, 1 adaptador del vial | 500 UI | 80 | 1 | 34 | 1 vial, 1 jeringa precargada, 1 émbolo, 1 adaptador del vial | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1191374001/1191374001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191374001/1191374001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1974 | NOVO NORDISK PHARMA S.A. | 2019-10-07 | 1 | 1 | 1 | 2019-10-08 | 2019-10-07 | 1 | 2019-12-12 | View Edit Delete | ||||||||||||
| 726865 | 1191374002 | ESPEROCT 1000 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | ESPEROCT 1000 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE, 1 vial, 1 jeringa precargada, 1 émbolo, 1 adaptador del vial | 1000 UI | 80 | 1 | 34 | 1 vial, 1 jeringa precargada, 1 émbolo, 1 adaptador del vial | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1191374002/1191374002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191374002/1191374002_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1974 | NOVO NORDISK PHARMA S.A. | 2019-10-07 | 1 | 1 | 1 | 2019-10-08 | 2019-10-07 | 1 | 2019-12-12 | View Edit Delete | ||||||||||||
| 726501 | 1191374003 | ESPEROCT 1500 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | ESPEROCT 1500 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE, 1 vial, 1 jeringa precargada, 1 émbolo, 1 adaptador del vial | 1500 UI | 80 | 1 | 34 | 1 vial, 1 jeringa precargada, 1 émbolo, 1 adaptador del vial | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1191374003/1191374003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191374003/1191374003_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1974 | NOVO NORDISK PHARMA S.A. | 2019-10-07 | 1 | 1 | 1 | 2019-10-08 | 2019-10-07 | 1 | 2019-12-12 | View Edit Delete |
Page 107 of 1035, showing 20 records out of 20697 total, starting on record 2121, ending on 2140